Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 1
2002 2
2003 5
2004 2
2005 9
2006 3
2007 9
2008 12
2009 6
2010 9
2011 9
2012 10
2013 10
2014 13
2015 5
2016 5
2017 13
2018 6
2019 9
2020 8
2021 13
2022 6
2023 7
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

154 results

Results by year

Filters applied: . Clear all
Page 1
Zilebesiran, an RNA Interference Therapeutic Agent for Hypertension.
Desai AS, Webb DJ, Taubel J, Casey S, Cheng Y, Robbie GJ, Foster D, Huang SA, Rhyee S, Sweetser MT, Bakris GL. Desai AS, et al. Among authors: huang sa. N Engl J Med. 2023 Jul 20;389(3):228-238. doi: 10.1056/NEJMoa2208391. N Engl J Med. 2023. PMID: 37467498 Clinical Trial.
Response.
Rajamani A, Galarza L, Sanfilippo F, Wong A, Goffi A, Tuinman P, Mayo P, Arntfield R, Fisher R, Chew M, Slama M, Mackenzie D, Ho E, Smith L, Renner M, Tavares M, Natesh Prabu R, Ramanathan K, Knudsen S, Bhat V, Arvind H, Huang S. Rajamani A, et al. Among authors: huang s. Chest. 2022 Jun;161(6):e401-e402. doi: 10.1016/j.chest.2022.01.061. Chest. 2022. PMID: 35680334 No abstract available.
Evaluation of RNAi therapeutics VIR-2218 and ALN-HBV for chronic hepatitis B: Results from randomized clinical trials.
Gane E, Lim YS, Kim JB, Jadhav V, Shen L, Bakardjiev AI, Huang SA, Cathcart AL, Lempp FA, Janas MM, Cloutier DJ, Kaittanis C, Sepp-Lorenzino L, Hinkle G, Taubel J, Haslett P, Milstein S, Anglero-Rodriguez YI, Hebner CM, Pang PS, Yuen MF. Gane E, et al. Among authors: huang sa. J Hepatol. 2023 Oct;79(4):924-932. doi: 10.1016/j.jhep.2023.05.023. Epub 2023 Jun 7. J Hepatol. 2023. PMID: 37290591 Free article.
Measuring cardiac output at the bedside.
Huang SJ. Huang SJ. Curr Opin Crit Care. 2019 Jun;25(3):266-272. doi: 10.1097/MCC.0000000000000599. Curr Opin Crit Care. 2019. PMID: 31022088 Review.
Phase 3 Trials of Tirbanibulin Ointment for Actinic Keratosis.
Blauvelt A, Kempers S, Lain E, Schlesinger T, Tyring S, Forman S, Ablon G, Martin G, Wang H, Cutler DL, Fang J, Kwan MR; Phase 3 Tirbanibulin for Actinic Keratosis Group. Blauvelt A, et al. N Engl J Med. 2021 Feb 11;384(6):512-520. doi: 10.1056/NEJMoa2024040. N Engl J Med. 2021. PMID: 33567191 Clinical Trial.
Sudden cardiac death in athletes.
Lorvidhaya P, Stephen Huang SK. Lorvidhaya P, et al. Among authors: stephen huang sk. Cardiology. 2003;100(4):186-95. doi: 10.1159/000074812. Cardiology. 2003. PMID: 14713730 Review.
Investigating sepsis with biomarkers.
McLean AS, Tang B, Huang SJ. McLean AS, et al. Among authors: huang sj. BMJ. 2015 Jan 28;350:h254. doi: 10.1136/bmj.h254. BMJ. 2015. PMID: 25630835 No abstract available.
Commentary.
Huang SA. Huang SA. Clin Chem. 2014 Jun;60(6):821. doi: 10.1373/clinchem.2013.214304. Clin Chem. 2014. PMID: 24872367 No abstract available.
154 results